EichorEICHOR
Study identifier: NCT06458907 Synced from ClinicalTrials.gov · August 04, 2026
● Not Yet Recruiting

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

Condition: Tricuspid Valve Disease · Heart Valve Diseases · Cardiovascular Diseases  ·  Sponsor: P+F Products + Features USA Inc.

PhaseNA
Planned participants780
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Pivotal trial to evaluate the safety and effectiveness of the P\&F TricValve® Transcatheter Bicaval Valve System.

This description comes directly from the study's public registry record.

Talk to the study team

Thuy Olender  ·  +1 408-839-3809  ·  tolender@productsandfeatures.com

Always discuss trial participation with your own doctor first.

Locations (34)

University of AlabamaBirmingham, Alabama, United States
St. Joseph's Hospital and Medical CenterPhoenix, Arizona, United States
UC Davis HealthSacramento, California, United States
Scripps Memorial Hospital La JollaSan Diego, California, United States
UCSFSan Francisco, California, United States
Kaiser PermanenteSan Jose, California, United States
MedStar Washington Hospital Center (MWHC)Washington D.C., District of Columbia, United States
Delray Medical CenterDelray Beach, Florida, United States
HCA Florida Largo HospitalLargo, Florida, United States
Tampa General HospitalTampa, Florida, United States
Endeavor HealthGlenview, Illinois, United States
Ascension Medical Group St. Vincent The Heart Center of IndianaIndianapolis, Indiana, United States

+ 22 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →